Gliomas, which account for almost half of all central nervous system tumors (1), often affect middle-aged individuals and cause severe social problems. In the US approx. 20,000 cases per year are reported. The corresponding figure for Sweden is 300, and in the Federal Republic of Germany the incidence is estimated to 1/10,000. The prognosis for the malignant forms is very bad, and despite surgical excision followed by irradiation and chemotherapy there has not been any significant increase of the surrival time, which is approx. one year. This might be attributed to a number of factors such as the invasive growth, without sharp delimitation from surrounding normal tissue, the great heterogeneity within the same tumor and the lack of knowledge about the biology of the tumors. Monoclonal antibodies to tumor-associated antigens could prove very helpful in increasing our knowledge of the biology of gliomas and in improving diagnosis and therapy. However, the usefulness of such an antibody depends on its specificity, and those produced so far have shown questionable specificity (2).
KeywordsHydrolysis Migration Carbohydrate Adenocarcinoma Glycol
Unable to display preview. Download preview PDF.
- 1.Russel DC, Rubinstein LJ (eds) (1977) Pathology of tumours of the nervous system. William and Wilkins Co, Baltimore.Google Scholar
- 2.Bourdon MA, Coleman RE, Bigner DD (1984) The potential of monoclonal antibodies as carrier of radiation and drugs for immunodetection and therapy of brain tumours, in Prog Exp Tumor Res (eds ML Rosenblum and CB Wilson) Karger AC, Basel 28: 79–101.Google Scholar
- 7.Zülch KJ (1979) Histological typing of tumours of the central nervous system. International histological classification of tumours No 21. World Health organization, Geneva.Google Scholar
- 8.Fredman P, von Hoist H, Collins VP, Ammar A, Dellheden B, Wahren B, Granholm L, Svennerholm L (1985) Potential ganglioside antigens associated with human gliomas. Neurol Res 8: 123–126.Google Scholar
- 14.Berra B, Gaini SM, Riboni L (1985) Correlation between ganglioside distribution and histological grading of human astrocytoma. 36: 363–366.Google Scholar
- 17.Schengrund C-L, Repman MA, Shochat SJ (1985) Ganglioside composition of human neuroblastomas 56: 2640–2646.Google Scholar
- 19.Peak JD, Berry PJ, Pennock CA (1986) Abnormal ganglioside in neuroblastoma. Lancet June 14.Google Scholar
- 20.Schuby G, Cheresh DA, Varki NM, Yu A, Staffileno LK, Reisfeld RA (1984) Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res 44: 5914–5920.Google Scholar
- 21.Ladisch S, Wu Z-L (1985) Detection of a tumour-associated ganglioside in plasma of patients with neuroblastomas. Lancet i 136–138.Google Scholar
- 26.Fredman P, Svennerholm L, Wikstrand CJ, Bigner SH, Mark J, Bigner DD (1986) Canglioside in eleven different established human glioma cell lines. Submitted to J Neuropath Exp Neurol.Google Scholar
- 27.Holmgen J, Lindblad M, Fredman P, Svennerholm L, Myrvold H (1985) Comparison of receptors for Cholera and Esherichia coli enterotoxins in human intestine. Gastroenterology 89: 27–35.Google Scholar
- 36.Molin K, Månsson J-E, Fredman P, Svennerholm L (1986) Sialosyllactotetraosylceramide 3′-LM1, a ganglioside of the lactotetraose series isolated from normal human infant brain. Submitted to J Neurochem.Google Scholar